Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMD) Current Deferred Revenue (2023 - 2025)

Historic Current Deferred Revenue for Baird Medical Investment Holdings (BDMD) over the last 3 years, with Q2 2025 value amounting to $282814.0.

  • Baird Medical Investment Holdings' Current Deferred Revenue rose 45157.39% to $282814.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $282814.0, marking a year-over-year increase of 45157.39%. This contributed to the annual value of $792102.0 for FY2024, which is 5845.05% up from last year.
  • Per Baird Medical Investment Holdings' latest filing, its Current Deferred Revenue stood at $282814.0 for Q2 2025, which was up 45157.39% from $792102.0 recorded in Q4 2024.
  • In the past 5 years, Baird Medical Investment Holdings' Current Deferred Revenue ranged from a high of $792102.0 in Q4 2024 and a low of $51274.0 during Q2 2024
  • Its 3-year average for Current Deferred Revenue is $406523.8, with a median of $391359.5 in 2023.
  • As far as peak fluctuations go, Baird Medical Investment Holdings' Current Deferred Revenue surged by 5845.05% in 2024, and later surged by 45157.39% in 2025.
  • Quarter analysis of 3 years shows Baird Medical Investment Holdings' Current Deferred Revenue stood at $499905.0 in 2023, then surged by 58.45% to $792102.0 in 2024, then tumbled by 64.3% to $282814.0 in 2025.
  • Its Current Deferred Revenue stands at $282814.0 for Q2 2025, versus $792102.0 for Q4 2024 and $51274.0 for Q2 2024.